EU News
Printable version

COVID-19 vaccines: Public Health Committee MEPs to quiz Commission

The EU’s lead negotiator on COVID-19 vaccines contracts, Sandra Gallina, will update MEPs on the latest developments concerning COVID-19 vaccines, on Tuesday at 9 am.

This will be followed by a Q&A session, where MEPs from the Committee on Environment, Public Health and Food Safety will quiz her on issues such as the EU’s procedure to approve the vaccines, what stage of the review process various vaccines have reached as well as the quantities bought by the EU.

At the Plenary session in December 2020, Parliament expressed support for speedy authorisation of safe vaccines. The Commission has since given conditional marketing authorisation for two COVID-19 vaccines, one developed by BioNTech and Pfizer and one by Moderna Biotech Spain, S.L. after the European Medicines Agency (EMA) concluded its assessments of these vaccines. On 8 January 2021, the Commission proposed purchasing up to 300 million additional doses of the BioNTech-Pfizer vaccine, bringing the total doses secured from the most promising vaccine candidates for Europe and its neighbourhood to 2.3 billion through advance purchase agreements with several pharmaceutical laboratories.

You can follow the committee meeting live here from 9 am on Tuesday 12 January.

Click here for the full press release


Original article link:

Share this article

Latest News from
EU News

Cyber Security: Nine Steps for Maturing Beyond Checkbox Compliance